nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP2D6—Sorafenib—liver cancer	0.105	0.38	CbGbCtD
Ranolazine—CYP3A4—Sorafenib—liver cancer	0.0667	0.242	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—liver cancer	0.0636	0.231	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—liver cancer	0.0404	0.147	CbGbCtD
Ranolazine—Renal failure acute—Sorafenib—liver cancer	0.0102	0.0156	CcSEcCtD
Ranolazine—Pain in extremity—Sorafenib—liver cancer	0.00937	0.0144	CcSEcCtD
Ranolazine—Dehydration—Sorafenib—liver cancer	0.00872	0.0134	CcSEcCtD
Ranolazine—Breast disorder—Sorafenib—liver cancer	0.00847	0.013	CcSEcCtD
Ranolazine—Pancreatitis—Sorafenib—liver cancer	0.00794	0.0122	CcSEcCtD
Ranolazine—Abdominal discomfort—Sorafenib—liver cancer	0.00777	0.0119	CcSEcCtD
Ranolazine—Serum creatinine increased—Epirubicin—liver cancer	0.00776	0.0119	CcSEcCtD
Ranolazine—Thrombocytosis—Epirubicin—liver cancer	0.00767	0.0118	CcSEcCtD
Ranolazine—Erectile dysfunction—Sorafenib—liver cancer	0.00746	0.0114	CcSEcCtD
Ranolazine—Parosmia—Epirubicin—liver cancer	0.00736	0.0113	CcSEcCtD
Ranolazine—Weight decreased—Sorafenib—liver cancer	0.00733	0.0112	CcSEcCtD
Ranolazine—Serum creatinine increased—Doxorubicin—liver cancer	0.00718	0.011	CcSEcCtD
Ranolazine—Thrombocytosis—Doxorubicin—liver cancer	0.0071	0.0109	CcSEcCtD
Ranolazine—Renal failure—Sorafenib—liver cancer	0.0071	0.0109	CcSEcCtD
Ranolazine—Epistaxis—Sorafenib—liver cancer	0.00681	0.0104	CcSEcCtD
Ranolazine—Parosmia—Doxorubicin—liver cancer	0.00681	0.0104	CcSEcCtD
Ranolazine—Carvedilol—VEGFA—liver cancer	0.00666	0.428	CrCbGaD
Ranolazine—Dermatitis atopic—Epirubicin—liver cancer	0.00645	0.00989	CcSEcCtD
Ranolazine—Urinary tract disorder—Sorafenib—liver cancer	0.0064	0.00982	CcSEcCtD
Ranolazine—Connective tissue disorder—Sorafenib—liver cancer	0.00637	0.00977	CcSEcCtD
Ranolazine—Urethral disorder—Sorafenib—liver cancer	0.00636	0.00975	CcSEcCtD
Ranolazine—Tinnitus—Sorafenib—liver cancer	0.00604	0.00927	CcSEcCtD
Ranolazine—Cardiac disorder—Sorafenib—liver cancer	0.00602	0.00923	CcSEcCtD
Ranolazine—Dermatitis atopic—Doxorubicin—liver cancer	0.00596	0.00915	CcSEcCtD
Ranolazine—Angiopathy—Sorafenib—liver cancer	0.00588	0.00902	CcSEcCtD
Ranolazine—Mediastinal disorder—Sorafenib—liver cancer	0.00584	0.00896	CcSEcCtD
Ranolazine—Arrhythmia—Sorafenib—liver cancer	0.00579	0.00888	CcSEcCtD
Ranolazine—Mental disorder—Sorafenib—liver cancer	0.00568	0.00871	CcSEcCtD
Ranolazine—Malnutrition—Sorafenib—liver cancer	0.00564	0.00866	CcSEcCtD
Ranolazine—Muscle spasms—Sorafenib—liver cancer	0.00543	0.00832	CcSEcCtD
Ranolazine—Angioedema—Sorafenib—liver cancer	0.00516	0.00791	CcSEcCtD
Ranolazine—Syncope—Sorafenib—liver cancer	0.00506	0.00776	CcSEcCtD
Ranolazine—Leukopenia—Sorafenib—liver cancer	0.00505	0.00775	CcSEcCtD
Ranolazine—Creatinine increased—Epirubicin—liver cancer	0.00501	0.00769	CcSEcCtD
Ranolazine—Loss of consciousness—Sorafenib—liver cancer	0.00496	0.00761	CcSEcCtD
Ranolazine—Cough—Sorafenib—liver cancer	0.00492	0.00755	CcSEcCtD
Ranolazine—Gait disturbance—Epirubicin—liver cancer	0.00489	0.0075	CcSEcCtD
Ranolazine—Coordination abnormal—Epirubicin—liver cancer	0.00486	0.00745	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00477	0.00732	CcSEcCtD
Ranolazine—Dry mouth—Sorafenib—liver cancer	0.0047	0.00721	CcSEcCtD
Ranolazine—Creatinine increased—Doxorubicin—liver cancer	0.00464	0.00711	CcSEcCtD
Ranolazine—Shock—Sorafenib—liver cancer	0.00453	0.00695	CcSEcCtD
Ranolazine—Gait disturbance—Doxorubicin—liver cancer	0.00452	0.00694	CcSEcCtD
Ranolazine—Nervous system disorder—Sorafenib—liver cancer	0.00452	0.00693	CcSEcCtD
Ranolazine—Thrombocytopenia—Sorafenib—liver cancer	0.00451	0.00692	CcSEcCtD
Ranolazine—Blood urea increased—Epirubicin—liver cancer	0.0045	0.00691	CcSEcCtD
Ranolazine—Coordination abnormal—Doxorubicin—liver cancer	0.0045	0.0069	CcSEcCtD
Ranolazine—Skin disorder—Sorafenib—liver cancer	0.00447	0.00686	CcSEcCtD
Ranolazine—Anorexia—Sorafenib—liver cancer	0.00439	0.00673	CcSEcCtD
Ranolazine—Blood urea increased—Doxorubicin—liver cancer	0.00417	0.00639	CcSEcCtD
Ranolazine—Dyspnoea—Sorafenib—liver cancer	0.00411	0.0063	CcSEcCtD
Ranolazine—Dyspepsia—Sorafenib—liver cancer	0.00405	0.00622	CcSEcCtD
Ranolazine—Decreased appetite—Sorafenib—liver cancer	0.004	0.00614	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00398	0.0061	CcSEcCtD
Ranolazine—Fatigue—Sorafenib—liver cancer	0.00397	0.00609	CcSEcCtD
Ranolazine—Constipation—Sorafenib—liver cancer	0.00394	0.00604	CcSEcCtD
Ranolazine—Gastrointestinal pain—Sorafenib—liver cancer	0.00377	0.00578	CcSEcCtD
Ranolazine—Renal failure acute—Epirubicin—liver cancer	0.00375	0.00575	CcSEcCtD
Ranolazine—Hot flush—Epirubicin—liver cancer	0.0037	0.00568	CcSEcCtD
Ranolazine—Menopausal symptoms—Epirubicin—liver cancer	0.00367	0.00563	CcSEcCtD
Ranolazine—Urticaria—Sorafenib—liver cancer	0.00366	0.00561	CcSEcCtD
Ranolazine—Abdominal pain—Sorafenib—liver cancer	0.00364	0.00559	CcSEcCtD
Ranolazine—Lethargy—Epirubicin—liver cancer	0.00353	0.00542	CcSEcCtD
Ranolazine—Renal failure acute—Doxorubicin—liver cancer	0.00347	0.00532	CcSEcCtD
Ranolazine—Diplopia—Epirubicin—liver cancer	0.00346	0.00531	CcSEcCtD
Ranolazine—Pain in extremity—Epirubicin—liver cancer	0.00346	0.00531	CcSEcCtD
Ranolazine—Hot flush—Doxorubicin—liver cancer	0.00343	0.00525	CcSEcCtD
Ranolazine—Menopausal symptoms—Doxorubicin—liver cancer	0.0034	0.00521	CcSEcCtD
Ranolazine—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.00339	0.0595	CbGpPWpGaD
Ranolazine—Asthenia—Sorafenib—liver cancer	0.0033	0.00507	CcSEcCtD
Ranolazine—Lethargy—Doxorubicin—liver cancer	0.00327	0.00502	CcSEcCtD
Ranolazine—Pruritus—Sorafenib—liver cancer	0.00326	0.005	CcSEcCtD
Ranolazine—Carvedilol—CYP2E1—liver cancer	0.00326	0.209	CrCbGaD
Ranolazine—Blood creatinine increased—Epirubicin—liver cancer	0.00324	0.00498	CcSEcCtD
Ranolazine—Dehydration—Epirubicin—liver cancer	0.00322	0.00494	CcSEcCtD
Ranolazine—Carvedilol—CYP1A1—liver cancer	0.00321	0.206	CrCbGaD
Ranolazine—Pain in extremity—Doxorubicin—liver cancer	0.0032	0.00492	CcSEcCtD
Ranolazine—Diplopia—Doxorubicin—liver cancer	0.0032	0.00492	CcSEcCtD
Ranolazine—Orthostatic hypotension—Epirubicin—liver cancer	0.00316	0.00485	CcSEcCtD
Ranolazine—Breast disorder—Epirubicin—liver cancer	0.00313	0.0048	CcSEcCtD
Ranolazine—Dizziness—Sorafenib—liver cancer	0.00305	0.00467	CcSEcCtD
Ranolazine—Blood creatinine increased—Doxorubicin—liver cancer	0.003	0.00461	CcSEcCtD
Ranolazine—Dehydration—Doxorubicin—liver cancer	0.00298	0.00457	CcSEcCtD
Ranolazine—Eosinophilia—Epirubicin—liver cancer	0.00296	0.00455	CcSEcCtD
Ranolazine—Pancreatitis—Epirubicin—liver cancer	0.00293	0.0045	CcSEcCtD
Ranolazine—Vomiting—Sorafenib—liver cancer	0.00293	0.00449	CcSEcCtD
Ranolazine—Orthostatic hypotension—Doxorubicin—liver cancer	0.00293	0.00449	CcSEcCtD
Ranolazine—Rash—Sorafenib—liver cancer	0.0029	0.00445	CcSEcCtD
Ranolazine—Dermatitis—Sorafenib—liver cancer	0.0029	0.00445	CcSEcCtD
Ranolazine—Breast disorder—Doxorubicin—liver cancer	0.0029	0.00444	CcSEcCtD
Ranolazine—Headache—Sorafenib—liver cancer	0.00289	0.00443	CcSEcCtD
Ranolazine—Pancytopenia—Epirubicin—liver cancer	0.00284	0.00436	CcSEcCtD
Ranolazine—Dysuria—Epirubicin—liver cancer	0.0028	0.00429	CcSEcCtD
Ranolazine—Eosinophilia—Doxorubicin—liver cancer	0.00274	0.00421	CcSEcCtD
Ranolazine—Nausea—Sorafenib—liver cancer	0.00274	0.0042	CcSEcCtD
Ranolazine—Pancreatitis—Doxorubicin—liver cancer	0.00272	0.00417	CcSEcCtD
Ranolazine—Weight decreased—Epirubicin—liver cancer	0.00271	0.00415	CcSEcCtD
Ranolazine—Pancytopenia—Doxorubicin—liver cancer	0.00263	0.00403	CcSEcCtD
Ranolazine—Renal failure—Epirubicin—liver cancer	0.00262	0.00402	CcSEcCtD
Ranolazine—Dysuria—Doxorubicin—liver cancer	0.00259	0.00397	CcSEcCtD
Ranolazine—Haematuria—Epirubicin—liver cancer	0.00254	0.0039	CcSEcCtD
Ranolazine—Epistaxis—Epirubicin—liver cancer	0.00252	0.00386	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—liver cancer	0.00251	0.00384	CcSEcCtD
Ranolazine—Propranolol—CYP1A1—liver cancer	0.00244	0.157	CrCbGaD
Ranolazine—Bradycardia—Epirubicin—liver cancer	0.00244	0.00374	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—liver cancer	0.00243	0.00372	CcSEcCtD
Ranolazine—Hypoaesthesia—Epirubicin—liver cancer	0.00238	0.00366	CcSEcCtD
Ranolazine—Urinary tract disorder—Epirubicin—liver cancer	0.00237	0.00363	CcSEcCtD
Ranolazine—Oedema peripheral—Epirubicin—liver cancer	0.00236	0.00362	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—liver cancer	0.00235	0.00361	CcSEcCtD
Ranolazine—Connective tissue disorder—Epirubicin—liver cancer	0.00235	0.00361	CcSEcCtD
Ranolazine—Urethral disorder—Epirubicin—liver cancer	0.00235	0.0036	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—liver cancer	0.00233	0.00357	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—liver cancer	0.00231	0.00354	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—liver cancer	0.00226	0.00346	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—liver cancer	0.00224	0.00343	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—liver cancer	0.00223	0.00343	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—liver cancer	0.00222	0.00341	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—liver cancer	0.00221	0.00338	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—liver cancer	0.00219	0.00336	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—liver cancer	0.00218	0.00335	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—liver cancer	0.00218	0.00334	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—liver cancer	0.00217	0.00333	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—liver cancer	0.00217	0.00333	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—liver cancer	0.00216	0.00331	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—liver cancer	0.00214	0.00328	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—liver cancer	0.00214	0.00328	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—liver cancer	0.0021	0.00322	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—liver cancer	0.00209	0.0032	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—liver cancer	0.00207	0.00318	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—liver cancer	0.00207	0.00317	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—liver cancer	0.00206	0.00316	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—liver cancer	0.00206	0.00315	CcSEcCtD
Ranolazine—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.00204	0.0358	CbGpPWpGaD
Ranolazine—Angiopathy—Doxorubicin—liver cancer	0.00201	0.00309	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—liver cancer	0.00201	0.00308	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—liver cancer	0.002	0.00306	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—liver cancer	0.00198	0.00304	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—liver cancer	0.00197	0.00302	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—liver cancer	0.00194	0.00298	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—liver cancer	0.00193	0.00296	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—liver cancer	0.0019	0.00292	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—liver cancer	0.00187	0.00287	CcSEcCtD
Ranolazine—Syncope—Epirubicin—liver cancer	0.00187	0.00287	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—liver cancer	0.00187	0.00286	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—liver cancer	0.00186	0.00285	CcSEcCtD
Ranolazine—Palpitations—Epirubicin—liver cancer	0.00184	0.00283	CcSEcCtD
Ranolazine—Loss of consciousness—Epirubicin—liver cancer	0.00183	0.00281	CcSEcCtD
Ranolazine—Cough—Epirubicin—liver cancer	0.00182	0.00279	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—liver cancer	0.00182	0.00279	CcSEcCtD
Ranolazine—Anxiety—Epirubicin—liver cancer	0.00177	0.00271	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00176	0.00271	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—liver cancer	0.00174	0.00266	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—liver cancer	0.00173	0.00266	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—liver cancer	0.00173	0.00265	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—liver cancer	0.00173	0.00265	CcSEcCtD
Ranolazine—Confusional state—Epirubicin—liver cancer	0.00172	0.00263	CcSEcCtD
Ranolazine—Palpitations—Doxorubicin—liver cancer	0.00171	0.00262	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—liver cancer	0.0017	0.0026	CcSEcCtD
Ranolazine—Cough—Doxorubicin—liver cancer	0.00168	0.00258	CcSEcCtD
Ranolazine—Shock—Epirubicin—liver cancer	0.00167	0.00257	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—liver cancer	0.00167	0.00256	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—liver cancer	0.00167	0.00256	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—liver cancer	0.00165	0.00254	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—liver cancer	0.00165	0.00252	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—liver cancer	0.00164	0.00251	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00163	0.0025	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—liver cancer	0.00162	0.00249	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—liver cancer	0.00161	0.00246	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—liver cancer	0.00159	0.00244	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—liver cancer	0.00159	0.00244	CcSEcCtD
Ranolazine—Shock—Doxorubicin—liver cancer	0.00155	0.00238	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—liver cancer	0.00154	0.00237	CcSEcCtD
Ranolazine—Thrombocytopenia—Doxorubicin—liver cancer	0.00154	0.00237	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—liver cancer	0.00154	0.00236	CcSEcCtD
Ranolazine—Skin disorder—Doxorubicin—liver cancer	0.00153	0.00235	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—liver cancer	0.00153	0.00234	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—liver cancer	0.00152	0.00234	CcSEcCtD
Ranolazine—Dyspnoea—Epirubicin—liver cancer	0.00152	0.00233	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—liver cancer	0.00151	0.00232	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—liver cancer	0.0015	0.0023	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—liver cancer	0.0015	0.0023	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—liver cancer	0.00148	0.00227	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—liver cancer	0.00147	0.00226	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00147	0.00225	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—liver cancer	0.00147	0.00225	CcSEcCtD
Ranolazine—Constipation—Epirubicin—liver cancer	0.00146	0.00223	CcSEcCtD
Ranolazine—Insomnia—Doxorubicin—liver cancer	0.00142	0.00219	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—liver cancer	0.00141	0.00217	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—liver cancer	0.0014	0.00215	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—liver cancer	0.0014	0.00215	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—liver cancer	0.0014	0.00215	CcSEcCtD
Ranolazine—Gastrointestinal pain—Epirubicin—liver cancer	0.00139	0.00214	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—liver cancer	0.00139	0.00213	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—liver cancer	0.00137	0.0021	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00136	0.00209	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—liver cancer	0.00136	0.00208	CcSEcCtD
Ranolazine—Urticaria—Epirubicin—liver cancer	0.00135	0.00207	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—liver cancer	0.00135	0.00207	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—liver cancer	0.00135	0.00206	CcSEcCtD
Ranolazine—CYP2D6—CYP2E1 reactions—CYP2E1—liver cancer	0.00133	0.0233	CbGpPWpGaD
Ranolazine—Feeling abnormal—Doxorubicin—liver cancer	0.0013	0.00199	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00129	0.00198	CcSEcCtD
Ranolazine—Urticaria—Doxorubicin—liver cancer	0.00125	0.00192	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—liver cancer	0.00125	0.00191	CcSEcCtD
Ranolazine—Asthenia—Epirubicin—liver cancer	0.00122	0.00187	CcSEcCtD
Ranolazine—Pruritus—Epirubicin—liver cancer	0.0012	0.00185	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—EFNB2—liver cancer	0.00117	0.0205	CbGpPWpGaD
Ranolazine—Asthenia—Doxorubicin—liver cancer	0.00113	0.00173	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—liver cancer	0.00113	0.00173	CcSEcCtD
Ranolazine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00112	0.0197	CbGpPWpGaD
Ranolazine—Pruritus—Doxorubicin—liver cancer	0.00111	0.00171	CcSEcCtD
Ranolazine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.0011	0.0194	CbGpPWpGaD
Ranolazine—Vomiting—Epirubicin—liver cancer	0.00108	0.00166	CcSEcCtD
Ranolazine—Rash—Epirubicin—liver cancer	0.00107	0.00165	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—liver cancer	0.00107	0.00164	CcSEcCtD
Ranolazine—Headache—Epirubicin—liver cancer	0.00107	0.00164	CcSEcCtD
Ranolazine—Dizziness—Doxorubicin—liver cancer	0.00104	0.0016	CcSEcCtD
Ranolazine—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.00103	0.018	CbGpPWpGaD
Ranolazine—Nausea—Epirubicin—liver cancer	0.00101	0.00155	CcSEcCtD
Ranolazine—Vomiting—Doxorubicin—liver cancer	0.001	0.00154	CcSEcCtD
Ranolazine—Rash—Doxorubicin—liver cancer	0.000993	0.00152	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—liver cancer	0.000992	0.00152	CcSEcCtD
Ranolazine—Headache—Doxorubicin—liver cancer	0.000987	0.00151	CcSEcCtD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.000982	0.0173	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—IGF2—liver cancer	0.000971	0.0171	CbGpPWpGaD
Ranolazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.000943	0.0166	CbGpPWpGaD
Ranolazine—Nausea—Doxorubicin—liver cancer	0.000936	0.00144	CcSEcCtD
Ranolazine—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.000907	0.0159	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—EFNB2—liver cancer	0.000834	0.0147	CbGpPWpGaD
Ranolazine—CYP2D6—Xenobiotics—CYP2E1—liver cancer	0.000822	0.0144	CbGpPWpGaD
Ranolazine—CYP2D6—Tamoxifen metabolism—CYP2E1—liver cancer	0.00079	0.0139	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—KDR—liver cancer	0.000739	0.013	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—MAPK14—liver cancer	0.000734	0.0129	CbGpPWpGaD
Ranolazine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.000731	0.0128	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—EFNB2—liver cancer	0.000728	0.0128	CbGpPWpGaD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000706	0.0124	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—TRIO—liver cancer	0.0007	0.0123	CbGpPWpGaD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000666	0.0117	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.000645	0.0113	CbGpPWpGaD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.000642	0.0113	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000634	0.0111	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000626	0.011	CbGpPWpGaD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000593	0.0104	CbGpPWpGaD
Ranolazine—CYP2D6—Xenobiotics—CYP1A1—liver cancer	0.00059	0.0104	CbGpPWpGaD
Ranolazine—CYP2D6—Tamoxifen metabolism—CYP1A1—liver cancer	0.000568	0.00997	CbGpPWpGaD
Ranolazine—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.000537	0.00944	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EFNB2—liver cancer	0.00052	0.00913	CbGpPWpGaD
Ranolazine—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000517	0.00908	CbGpPWpGaD
Ranolazine—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.000514	0.00903	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000508	0.00892	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TRIO—liver cancer	0.0005	0.00878	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TCF4—liver cancer	0.00047	0.00825	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—UGDH—liver cancer	0.000462	0.00811	CbGpPWpGaD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000461	0.00811	CbGpPWpGaD
Ranolazine—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.000443	0.00778	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—CYP1A1—liver cancer	0.000439	0.0077	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—TRIO—liver cancer	0.000436	0.00766	CbGpPWpGaD
Ranolazine—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00042	0.00738	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00041	0.00719	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—HNF4A—liver cancer	0.000407	0.00716	CbGpPWpGaD
Ranolazine—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000402	0.00706	CbGpPWpGaD
Ranolazine—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000386	0.00678	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—liver cancer	0.000374	0.00657	CbGpPWpGaD
Ranolazine—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000371	0.00652	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—ABL1—liver cancer	0.000368	0.00646	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000351	0.00617	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000341	0.00599	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000337	0.00591	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000332	0.00583	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TRIO—liver cancer	0.000311	0.00547	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000302	0.0053	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TCF4—liver cancer	0.000293	0.00514	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—KDR—liver cancer	0.000279	0.0049	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000277	0.00486	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000276	0.00485	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MET—liver cancer	0.000273	0.00479	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—NR1H4—liver cancer	0.00027	0.00474	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTA3—liver cancer	0.000265	0.00466	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ABL1—liver cancer	0.000263	0.00461	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTA3—liver cancer	0.000262	0.00459	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—HNF4A—liver cancer	0.000254	0.00446	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000245	0.00431	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTA4—liver cancer	0.000243	0.00426	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000242	0.00425	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTA4—liver cancer	0.000239	0.0042	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTA2—liver cancer	0.000236	0.00415	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000231	0.00406	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ABL1—liver cancer	0.000229	0.00403	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTA1—liver cancer	0.000228	0.00401	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MMP2—liver cancer	0.000228	0.004	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—NAT2—liver cancer	0.000225	0.00396	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000223	0.00392	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000222	0.00391	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00022	0.00387	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PPARA—liver cancer	0.000214	0.00376	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000202	0.00355	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—RAF1—liver cancer	0.000202	0.00354	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—KDR—liver cancer	0.000199	0.00349	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000199	0.00349	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000198	0.00348	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MAPK14—liver cancer	0.000198	0.00347	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—JUN—liver cancer	0.000197	0.00345	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000195	0.00343	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MET—liver cancer	0.000195	0.00342	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000191	0.00335	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000189	0.00332	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000181	0.00318	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.00018	0.00317	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PPARG—liver cancer	0.000177	0.00311	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000176	0.0031	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—KDR—liver cancer	0.000174	0.00305	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000173	0.00305	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000172	0.00302	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MMP9—liver cancer	0.000171	0.003	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000171	0.003	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MET—liver cancer	0.00017	0.00299	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ABL1—liver cancer	0.000164	0.00287	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MMP2—liver cancer	0.000162	0.00285	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00016	0.00282	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000159	0.00279	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000158	0.00278	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000156	0.00275	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000155	0.00271	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—VEGFA—liver cancer	0.000154	0.0027	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000149	0.00262	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000147	0.00259	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TNF—liver cancer	0.000147	0.00258	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000147	0.00258	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000145	0.00255	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.000145	0.00255	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—RAF1—liver cancer	0.000144	0.00253	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MMP2—liver cancer	0.000142	0.00249	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GGT1—liver cancer	0.000135	0.00237	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PPARA—liver cancer	0.000133	0.00234	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—KRAS—liver cancer	0.000131	0.00229	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00013	0.00228	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—RAF1—liver cancer	0.000126	0.00221	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CTNNB1—liver cancer	0.000125	0.00219	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KDR—liver cancer	0.000124	0.00218	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000124	0.00217	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAPK14—liver cancer	0.000123	0.00216	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MMP9—liver cancer	0.000122	0.00214	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MET—liver cancer	0.000121	0.00213	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.000121	0.00213	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.00012	0.0021	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL6—liver cancer	0.000119	0.00209	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000118	0.00207	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000111	0.00196	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—HRAS—liver cancer	0.000111	0.00195	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PPARG—liver cancer	0.00011	0.00194	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.00011	0.00193	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—VEGFA—liver cancer	0.00011	0.00193	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—STAT3—liver cancer	0.000109	0.00191	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MMP9—liver cancer	0.000107	0.00187	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—IL6—liver cancer	0.000106	0.00187	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000106	0.00185	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000104	0.00183	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP2—liver cancer	0.000101	0.00178	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TGFB1—liver cancer	0.000101	0.00177	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	9.61e-05	0.00169	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—VEGFA—liver cancer	9.57e-05	0.00168	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	9.48e-05	0.00166	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TNF—liver cancer	9.39e-05	0.00165	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—KRAS—liver cancer	9.32e-05	0.00164	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RAF1—liver cancer	8.96e-05	0.00157	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GGT1—liver cancer	8.82e-05	0.00155	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—KRAS—liver cancer	8.13e-05	0.00143	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTP1—liver cancer	7.92e-05	0.00139	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—HRAS—liver cancer	7.92e-05	0.00139	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UGDH—liver cancer	7.9e-05	0.00139	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	7.81e-05	0.00137	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CTNNB1—liver cancer	7.76e-05	0.00136	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP9—liver cancer	7.6e-05	0.00134	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6—liver cancer	7.58e-05	0.00133	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—EPT1—liver cancer	7.42e-05	0.0013	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTM1—liver cancer	7.28e-05	0.00128	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	7.18e-05	0.00126	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TAT—liver cancer	7.04e-05	0.00124	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT1—liver cancer	6.99e-05	0.00123	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—HRAS—liver cancer	6.91e-05	0.00121	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	6.9e-05	0.00121	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—liver cancer	6.83e-05	0.0012	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	6.81e-05	0.0012	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—STAT3—liver cancer	6.76e-05	0.00119	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6—liver cancer	6.62e-05	0.00116	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TGFB1—liver cancer	6.27e-05	0.0011	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TNF—liver cancer	5.85e-05	0.00103	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KRAS—liver cancer	5.8e-05	0.00102	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UGDH—liver cancer	5.16e-05	0.000907	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—HRAS—liver cancer	4.93e-05	0.000867	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—EPT1—liver cancer	4.85e-05	0.000853	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CPT1B—liver cancer	4.78e-05	0.00084	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GLUL—liver cancer	4.78e-05	0.00084	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6—liver cancer	4.72e-05	0.000829	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NR1H4—liver cancer	4.61e-05	0.00081	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TAT—liver cancer	4.6e-05	0.000808	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA3—liver cancer	4.53e-05	0.000797	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT1—liver cancer	4.36e-05	0.000765	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA4—liver cancer	4.15e-05	0.000729	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA2—liver cancer	4.04e-05	0.00071	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA1—liver cancer	3.9e-05	0.000685	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NAT2—liver cancer	3.86e-05	0.000677	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALDOB—liver cancer	3.7e-05	0.000649	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CRABP1—liver cancer	3.53e-05	0.000619	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GLUL—liver cancer	3.13e-05	0.000549	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CPT1B—liver cancer	3.13e-05	0.000549	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HPGDS—liver cancer	3.08e-05	0.000541	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NR1H4—liver cancer	3.02e-05	0.00053	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA3—liver cancer	2.96e-05	0.000521	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PSMD10—liver cancer	2.75e-05	0.000483	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PSMA4—liver cancer	2.75e-05	0.000483	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA4—liver cancer	2.71e-05	0.000476	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GOT2—liver cancer	2.67e-05	0.000469	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA2—liver cancer	2.64e-05	0.000464	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA1—liver cancer	2.55e-05	0.000448	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NAT2—liver cancer	2.52e-05	0.000443	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2E1—liver cancer	2.51e-05	0.000441	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALDOB—liver cancer	2.42e-05	0.000425	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYCS—liver cancer	2.35e-05	0.000413	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GOT1—liver cancer	2.31e-05	0.000405	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GGT1—liver cancer	2.31e-05	0.000405	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CRABP1—liver cancer	2.31e-05	0.000405	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTP1—liver cancer	2.07e-05	0.000364	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HMOX1—liver cancer	2.04e-05	0.000359	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HPGDS—liver cancer	2.02e-05	0.000354	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTM1—liver cancer	1.9e-05	0.000335	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.81e-05	0.000317	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PSMA4—liver cancer	1.8e-05	0.000316	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PSMD10—liver cancer	1.8e-05	0.000316	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GOT2—liver cancer	1.75e-05	0.000307	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTHFR—liver cancer	1.68e-05	0.000296	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPARA—liver cancer	1.65e-05	0.00029	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.64e-05	0.000289	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYCS—liver cancer	1.54e-05	0.00027	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GOT1—liver cancer	1.51e-05	0.000265	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GGT1—liver cancer	1.51e-05	0.000265	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.41e-05	0.000248	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPARG—liver cancer	1.36e-05	0.00024	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTP1—liver cancer	1.35e-05	0.000238	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HMOX1—liver cancer	1.34e-05	0.000235	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTM1—liver cancer	1.25e-05	0.000219	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.24e-05	0.000218	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALB—liver cancer	1.23e-05	0.000216	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.18e-05	0.000207	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTHFR—liver cancer	1.1e-05	0.000193	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.08e-05	0.00019	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPARA—liver cancer	1.08e-05	0.00019	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CG—liver cancer	9.25e-06	0.000162	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPARG—liver cancer	8.92e-06	0.000157	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CD—liver cancer	8.13e-06	0.000143	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALB—liver cancer	8.02e-06	0.000141	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CB—liver cancer	7.08e-06	0.000124	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CA—liver cancer	6.61e-06	0.000116	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKT1—liver cancer	5.4e-06	9.48e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CA—liver cancer	4.32e-06	7.59e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKT1—liver cancer	3.53e-06	6.2e-05	CbGpPWpGaD
